Telomerase activity and lymphovascular invasion in breast cancer

European Journal of Surgical Oncology

Volumn 26, Issue 1, 2000, Pages 30-33

  Parris, C N ^a,b,d   Ghilchik, M ^a,b,d   Amerasinghe, C N ^a,b,d   Newbold, R F ^a,b,d   Mokbel, K M ^c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c Central Middlesex Hospital ^*

^d CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Breast; LVI; Telomerase

Indexed keywords

EOSIN; HEMATOXYLIN; TELOMERASE;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; CELL IMMORTALIZATION; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MENOPAUSE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033956926     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0736     Document Type: Article

References (19)

1. Morin GB. Cell. 59:1989;521-529.
2. Blackburn EH. Nature. 350:1991;569-573.
3. Kim NW, Piatyszek MA, Prowse KR. Specific association of human telomerase activity with immortal cells. Science. 266:1994;2011-2015.
4. Harley CB. Mutation Res. 256:1991;271-282.
5. Hiyama E, Gollahon L, Kataoka T. Telomerase activity in human breast tumours. J Natl Cancer Inst. 88:1996;116-122.
6. Clark GM, Osborne K, Levitt D. Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst. 89:1997;1874-1881.
7. Pinder SE, Ellis IO, Galea M. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow up. Histopathology. 24:1994;41-47.
8. Gilchrist KW, Gould VE, Hirsch S. Hum Pathol. 13:1982;170-172.
9. Bettelheim R, Penman HG, Thornton-Jones H. Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer. 50:1984;771-777.
10. Roses DF, Bell DA, Flotte TJ. Pathologic predictors of recurrence in stage I (TINOMO) breast cancer. Am J Clin Pathol. 78:1982;817-820.
11. Davis WB, Gelber R, Goldhirsch A. Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastases. Hum Pathol. 16:1985;1212-1218.
12. Dearnaley DP, Ormerod MG, Sloane JP. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer. 44:1981;85-90.
13. Redding WH, Coombes RC, Monogham P. Detection of micrometastases in patients with primary breast cancer. Lancet. 2:1983;1271-1274.
14. Rosen PP, Saigo PE, Braun DW. Predictors of recurrence in stage 1 (TINOMO) breast carcinomas. Ann Surg. 193:1980;15-25.
15. Olovotto IA, Jackson JS, Mates D. Prediction of axillary lymph node involvement of women with invasive breast carcinoma, a multivariate analysis. Cancer. 83:1998;948-955.
16. Fein DA, Fowble BL, Hanlon AL. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 65:1997;34-39.
17. Galea MH, Blamey RW, Elston CE. The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat. 22:1992;207-219.
18. Bosari S, Lee AKC, Tahan SR. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma. Cancer. 70:1992;1943-1950.
19. Roos G, Nilsson P, Cajander S. Telomerase activity in relation to p53 status and clinicopathological parameters in breast cancer. Int J Cancer. 79:1998;343-348.